Dravet Syndrome
Dravet Syndrome is a rare and complex neurological condition that presents from infancy. Affecting one in every 15,000 babies born in the UK,1 it can have lifelong consequences for people living with it and those who care for them.2,3 While seizures are its most recognised feature, Dravet Syndrome can also affect development, learning, behaviour and mobility, creating challenges that extend well beyond seizure management.4 Improving outcomes for people with Dravet Syndrome requires ongoing progress in diagnosis, treatment, care and support.
What is Dravet Syndrome?
Dravet Syndrome is a rare and life-long form of epilepsy that begins in infancy.1 It is characterised by frequent seizures that can be difficult to control or are resistant to treatment.5,6,7
Dravet Syndrome can also affect development, behaviour, movement and cognitive function. People living with the condition experience significant developmental and motor impairments that persist into adulthood and have an increased risk of sudden death known as Sudden Unexpected Death in Epilepsy (SUDEP).3,4
How common is Dravet Syndrome?
Dravet Syndrome is a rare condition that affects approximately one in every 15,000 babies born in the UK.1
What is living with Dravet Syndrome like?
Dravet Syndrome can have a significant physical and emotional impact on people living with the condition. Frequent and difficult-to-control seizures, together with developmental and movement-related challenges, can affect everyday life and create a need for ongoing care and support.8
These challenges can continue into adulthood, severely impacting the quality of life for patients, their families, and caregivers due to its high physical, emotional, and financial burden.2 Approximately 66% of caregivers experience depression due to the devastating nature of Dravet Syndrome.9
What causes Dravet Syndrome?
In most cases, Dravet Syndrome is caused by a change (mutation) in a gene called SCN1A, which plays an important role in how nerve cells in the brain function. These genetic changes usually occur spontaneously and are not inherited from a parent.1,9,10
Can Dravet Syndrome be cured?
There is currently no cure for Dravet Syndrome. However, treatment and supportive care can help to manage seizures and support quality of life.
What are the unmet needs in Dravet Syndrome care?
Despite the availability of multiple anti-seizure medicines, seizures associated with Dravet Syndrome can remain difficult to control.3 There therefore remains an unmet need for effective and tolerable treatments, alongside care and support that address the broader developmental and quality-of-life effects of the condition.
What is UCB's work in Dravet Syndrome?
As a leader in neurology, UCB is committed to the development of new solutions for rare forms of epilepsy that may help transform the lives of people living with severe neurological diseases, and we are acutely aware of the urgent unmet medical need that remains for people living with Dravet Syndrome for effective and tolerable treatments. We believe that collaborative working projects will deliver real results for the NHS and patients, which is why we have partnered with the NHS to support diagnosis and management of Dravet Syndrome.
We have witnessed first-hand the remarkable work of caregivers, nurses, doctors, therapists, and researchers to make every day a little better for Dravet Syndrome patients and their families.
Interested in UCB's approach to rare diseases?
The Aspire4Rare Framework is a global policy guidance framework developed by UCB and a multidisciplinary panel of rare disease experts. It aims to help governments, policymakers, healthcare systems, researchers, and patient organisations strengthen health systems for the estimated 300 million people living with rare diseases worldwide, offering a practical framework, measurable outcomes, and examples of good practice to guide rare disease policy development and implementation.
To learn more about Dravet Syndrome, visit Dravet Syndrome UK.
References
1. Dravet Syndrome UK. About Dravet Syndrome. Available at: https://www.dravet.org.uk/information-support/about-dravet-syndrome/ Last Accessed: October 2026
2. Gil-Nagel A, et al. Patient profile, management, and quality of life associated with Dravet syndrome: a cross-sectional, multicentre study of 80 patients in Spain. Sci Rep 2023; 13: 3355. https://doi.org/10.1038/s41598-023-30273-z.
3. Anwar A et al. Dravet Syndrome: An Overview. 2019 Cureus 11(6):e5006. DOI 10.7759/cureus.5006.
4. Lagae L, et al. Quality of Life and Comorbidities Associated with Dravet Syndrome Severity: a Multinational Cohort Survey. Dev Med Child Neurol 2018;60(1):63-72.
5. Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011;52 (Suppl 2):3-9. doi: 10.1111/j.1528-1167.2011.02994.x. PMID: 21463272.
6. Epilepsy Action. Dravet Syndrome. Available at: https://www.epilepsy.org.uk/info/syndromes/dravet-syndrome Last Accessed: October 2026
7. Adam Strzelczyk & Susanne Schubert-Bast (2020) Therapeutic advances in Dravet syndrome: a targeted literature review, Expert Review of Neurotherapeutics, 20:10, 1065-1079, DOI: 10.1080/14737175.2020.1801423.
8. Jan Domaradzki, et al. Living with Dravet syndrome: quality of life and caregiver burden among family caregivers in Europe. Results from the QoL4DRAVET study, Epilepsy & Behavior, Volume 183, 2026, 111176, ISSN 1525-5050, https://doi.org/10.1016/j.yebeh.2026.111176.
9. Villas N, Meskis MA, Goodliffe S. Dravet Syndrome: Characteristics, Comorbidities, and Caregiver Concerns. Epilepsy and Behavior. 2017 Sept 1; Volume 74, P81-86.
10. NINDS. Dravet syndrome. Available at: https://www.ninds.nih.gov/health-information/disorders/dravet-syndrome Last accessed: October 2026
Last updated: October 2026
IE-DA-2600395